A novel coronavirus (SARS-CoV-2) originated in 2019 in Wuhan, China. A new coronavirus not previously identified in humans, the virus causes COVID-19 disease, a highly transmittable disease - primarily via close person-to-person contact - that also displays varied severity and symptoms, challenging attempts to limit its spread. In this web session, Achim Regenauer, Chief Medical Officer of PartnerRe, presents the facts as we know them now, covering the key medical and epidemiological aspects relevant to the insurance industry. After this web session you will gain a clearer picture and understanding of the COVID-19 outbreak.

Organised by the EAA - European Actuarial Academy GmbH.

The web session is open to all interested persons working within the insurance industry.

Technical requirements and test session
Please check with your IT department if your firewall and computer settings support web session participation (the programme GoToTraining is used for the web session). Please also make sure that you are joining the web session with a stable internet connection. 

On 23 March  10:00 – 10:30 CET, there will be a test session offered to all registered participants to test the software.

The aim of this web session is to provide an overview of the Corona pandemic with a clear mandate to differentiate facts from emotional, “half-news”  or even fake news. It should also offer a guidance for a better understanding of possible implications for insurance industry, particularly life insurance.

The language of the web session will be English.

Dr. Achim Regenauer
is a specialist in internal medicine with many years of experience in clinical medicine before  joining reinsurance industry. Over several decades he has acquired  knowledge in risk management of international life insurance (case assessment,  development of guidelines, various forms and depths of underwriting, coaching, product counselling, claims, complaint management), partially also in the health and non-life areas of insurance.
Dr. Regenauer worked internationally for Munich Re at an executive level with additional engagements in various insurance associations (e.g. Board Member of the ICLAM and Chairman of the board of Department for Life Insurance Medicine in Germany), but also with frequent contact to actuarial organisations, governments and the media dealing with hot topics such as SARS and Avian influenza.
In the last years one of his major task has been to monitor and to analyze non-financial trends in medicine, technology, society and politics in terms of their impact on  life and health insurance.
As from  January 1,  2017 he joined  PartnerRe  as Chief Medical Officer dealing with  emerging topics such as pandemics, antimicrobial resistance, obesity etc. Major focus areas of his activities are longevity issues, underwriting, claims, critical illness, critical advantage, e-health and regular updates on Partner Re`s manual PAR (underwriting manual).